ICYMI: Highlights From IMS 2024
December 17th 2024The expert knowledge presented at this year’s International Myeloma Society (IMS) annual meeting focused on minimal residual disease testing and status, defining and treating high-risk disease, CEPHEUS trial findings, and an investigational off-the-shelf chimeric antigen receptor T-cell therapy.
Read More
Cosibelimab Approved for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
December 16th 2024The FDA has approved cosibelimab-ipdl for the treatment of adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.
Read More
Addressing Ovarian Cancer Outcome Disparities With Cultural Understanding, Disaggregated Research
December 16th 2024In the final part of our interview, Alice W. Lee, PhD, MPH, highlights the importance of addressing ovarian cancer care disparities and beyond by understanding cultural and behavioral factors and adopting a more disaggregated approach to research.
Read More
Health Equity & Access Weekly Roundup: December 15, 2024
December 15th 2024Recent analyses spotlight inequities in health care, from the financial burdens faced by employees at small firms due to higher insurance costs to disparities in data and ovarian cancer survival among racial and ethnic groups.
Read More
Experts Pinpoint AI, Predictive Analytics as Key to Addressing Health Care Challenges
December 13th 2024Experts at the Council for Affordable Quality Healthcare (CAQH) Connect 2024 emphasized the transformative potential of artificial intelligence (AI) and predictive analytics in addressing health care challenges, advancing equity, and reducing clinician burden.
Read More
Confronting Systemic Racial Inequities in Health Care Data Must Start With Employers
December 13th 2024Robin Glasgow, MBA, executive leadership advisor of Spencer Stuart, discusses the critical role of data in health care, emphasizing the need to address pervasive biases in data collection and algorithms.
Watch